Bristol-based international legal practice Osborne Clarke has advised Creo Medical Group an AIM-quoted medical devices company focusing on the emerging field of surgical endoscopy, on a fundraising, consisting of a placing, subscription and open offer, raising gross proceeds of £33.7 million.
The net proceeds of the fundraise are expected to resolve Chepstow-based Creo's funding gap with the expectation of providing it with a pathway to being cash flow breakeven and, ultimately, to profitability. In particular, the new capital will allow Creo to:
Cenkos Securities is acting as Creo's nominated adviser and Cenkos and Numis Securities Limited are acting as joint brokers in connection with the placing and open offer.
The Osborne Clarke team was led by corporate partner Mark Wesker, who was assisted by senior associates Rebecca Ewing and Adam Turner and associate Olivier Jacquelin. Osborne Clarke also advised Creo on its previous fundraises in 2021 and 2019.
Osborne Clarke’s corporate team, which is Band 1 ranked for Capital Markets: AIM by Chambers, is considered a go-to practice for many companies (in the life sciences & healthcare sector and beyond), working with global businesses to fast-growth start-ups and market challengers.
The team advises at every stage of company development across all corporate issues, from equity and debt fundraisings to strategic M&A, IPOs and JVs.
A new business incubation programme has launched at Harwell Campus in Oxfordshire, designed to help…
Reading law firm Boyes Turner has promoted five senior solicitors across its teams, following a strong start…
Aquark Technologies, a quantum tech company based in Southampton, has won a £3.4 million contract…
Dootrix has partnered with Confused.com to help streamline its mobile insurance app and plan new…
B P Collins is continuing its expansion through a merger with Cathcarts Solicitors, a West…
measurable.energy has launched a strategic partnership with national construction group Morgan Sindall. The Reading firm…